Vectorious Medical Technologies is a leading brand in the field of remote heart failure management. Founded in 2011 by Oren Goldshtein and Dr. Eyal Orion, MD, the company aimed to revolutionize implantable hemodynamic monitoring.

Traditionally, understanding a patient's heart required invasive catheter insertion, limiting accessibility and practicality. Vectorious sought to change that by harnessing technology to remotely monitor the heart's left atrial pressure. Using in-body microcomputers called V-LAP, they can provide accurate and specific physiological indications on a daily basis from the comfort of a patient's home.

By analyzing digitally generated data using AI-based analysis, Vectorious empowers caregivers to make informed treatment decisions and improve outcomes for heart failure patients. With successful clinical studies and global implantations, Vectorious is dedicated to helping millions of people manage their heart failure and live longer, fuller lives